The industry shaping agenda

Keynote sessions

00:00am – 00:00am (CET)

Overview:Reimagine pharma to unleash it's potential

  • Reimagine your commercial strategy to match the customer needs of tomorrow
  • Glimpse the technology of tomorrow that will change the fundamental shape of your business, removing entry barriers to new therapeutic areas
  • Pioneer patient-led innovation to ensure the greatest unmet need is fulfilled with your next blockbuster
  • Go beyond centres of excellence for digital, embedding it across your organisation and reach it's full potential

Marie-France Tschudin President, Pharmaceuticals Novartis

Catherine Mazzacco President & CEO LEO Pharma

Stefan Oerlich President, Pharmaceuticals Bayer

Myrtle Potter CEO Sumitovant Biopharma

Carinne Brouillon Head, Human Pharma, Board of Managing Directors Boehringer Ingelheim

Bill Sibold EVP and Head Sanofi Genzyme

00:00am – 00:00am (CET)

Overview:The future of European Healthcare

  • Shape the European healthcare system of the future through collaboration to align stakeholders around patient value and ensure access for future pharma innovation
  • European Pharmaceutical Strategy, a review: the first step to a more sustainable health future? See the impact of key legislation on your pipelines and future products
  • Democratise healthcare through a digital revolution, fuelled by the growing power of patient-owned health data
  • Prime your future strategies for the advent of smaller, more targeted patient population groups through the blueprint of rare disease engagement strategies

Nathalie Moll Director General EFPIA

Richard Daniell EVP, Head of Europe Commercial Teva

Giles Platford President, Europe & Canada Takeda

Commercial Excellence through digital transformation

00:00am – 00:00am (CET)

Fireside:Your burning platform! Create digital - and people - transformation during commercial pharma’s industrial revolution

  • Don’t get left behind. It’s now or never to increase digital capabilities, disrupt the market, and deliver true customer centricity
  • How to clearly outline new business priorities and get buy-in from those who will be affected the most to enable accelerated transformation
  • Digital isn't a channel, it's a way of doing business. Key principles for a digitally enabled commercial model that delivers improved experiences for HCPs, payers, patients, and peers

Nikos Georgiades SVP, Global Head of Digital Commercial Execution Novartis

00:00am – 00:00am (CET)

Panel:Stop cleanin’ windows and change the foundation. ‘Cause right now you’re doing digitization not digital transformation

  • Ensure a complete customer experience by reimaging the core customer engagement model - break silos and mold cross-functional teams to deliver personalised value
  • Overcome market archetype differences to get global and local on the same page to enable savings, efficiencies, and effectiveness
  • It’s not just innovation for innovation’s sake. Understand how to identify new capabilities that hit on your business strategy and deliver for customers and patients alike

Erasmus Holm Chief Marketing Officer, Nordics MSD

00:00am – 00:00am (CET)

Case study:Transform your customer engagement capabilities through more educated rep engagement and effective change management

  • Communicate the strategic vision of the company so the field force commits to new ways of working and you don’t lose them along the journey
  • Empower your reps! Maximize on rep insights to co-create strategy, solve specific customer pain points, and deliver on sales goals
  • Apply new tech to field operations to enable smoother planning to execution processes that are tailored for your customer needs
  • How to use an online educational content hub to trigger rep-driven conversations with HCPs for a connected customer journey

Laia Gil Molas Commercial Operations Manager, Iberia Alexion

00:00am – 00:00am (CET)

Sponsored Thought Leadership Opportunity

  • For more information, reach out to Henry Payne, Director of Business Development

00:00am – 00:00am (CET)

Case study:The keys to virtual launch success

  • How to use your digital transformation as the foundation for executing a fit-for-purpose launch excellence, without needing to re-invent the model
  • Develop your data-foundations, use predictive analytics and generate actionable insights on customer behaviors and profiles. Engage with customers on their terms.
  • Orchestrate an agile cross-functional team that can adjust strategy and delivery an integrated launch strategy

00:00am – 00:00am (CET)

Live Q&A: Commercial Excellence through digital transformation

  • Quiz our expert speakers on their case studies and their views on the future

Laia Gil Molas Commercial Operations Manager, Iberia Alexion

Go-to-Market Mastery

00:00am – 00:00am (CET)

Fireside:The GTM Model Evolved: A practical assessment from different markets to improve your customer engagement

  • Gain market share and maturity by understanding the variety of strategies, from content to patient services, needed to satisfy changing customer needs. A comprehensive perspective on the breadth of current advancements and where they’ll go next
  • Digital isn’t the be-all and end-all in a virtual world. How effective change management and establishing the appropriate cultural mindset are crucial in evolving your GTM model
  • Why integrated field strategies and reps still hold the trump cards to understanding customers and delivering exceptional launch results

Catherine Owen SVP, Major Markets Bristol Myers Squibb

00:00am – 00:00am (CET)

Panel:A data and digital enabled GTM strategy for long-term business impact

  • Equal voices at the strategy meeting: Why an aligned and cross-functional GTM strategy has never been more important – and how to balance strategic priorities
  • Working backwards. Define your channel and content mix based on customer behaviours and create experiences that HCPs crave
  • The new model tenet: How to build your remote capability through technology enablement and validate your hybrid selling model to ensure reps can hit their newly defined KPIs

Patrick Markt-Niederreiter Head, Digital Excellence, Europe Daiichi Sankyo

Chetak Buaria Global Head, Customer Engagement & Channel Evolution Merck KGaA

00:00am – 00:00am (CET)

Case study:The battle of digital and virtual fatigue: Make your HCP engagement meaningful

  • Get out of the reach and frequency fight. Enhance your customer experience by putting new forms of content and value-add interactions at the heart of your HCP engagement strategy
  • Make data actionable. How to spot technological deficiencies and create a cross-company infrastructure that enables a personalised approach
  • Create a holistic customer experience through a field force strategy that balances both digital and F2F interactions, and product and disease content

00:00am – 00:00am (CET)

Sponsored Thought Leadership Opportunity

  • For more information, reach out to Henry Payne, Director of Business Development

00:00am – 00:00am (CET)

Case study:Brand-team evolution is Customer-Centricity 2.0

  • A new go-to-market model that gives commercial, marketing and medical equal footing to create more value for your customers
  • Integrate digital activities from launch to help position your brand long-term and stay flexible as market changes occur. Make your brand plan iterative and don’t let it just sit on the shelf for a year.
  • Hear how successful brand teams are upskilling themselves to go even further in understanding all types of customers

00:00am – 00:00am (CET)

Live Q&A: Go-to-Market Mastery

  • Quiz our expert speakers on their case studies and their views on the future

Data centricity: for more intelligent decision-making and efficient commercial operations

00:00am – 00:00am (CET)

Fireside:The guidebook to creating a data-driven commercial organization

  • Get your entire organisation bought into the value of becoming data-driven by finding your change-makers to drive the project forward
  • Key principles to finding the technology and analytics partners that will serve your needs and create exceptional business outcomes
  • Data is alive. Understand why this isn’t a project, but a product evolution that is never finished

00:00am – 00:00am (CET)

Panel:Build your analytics muscle to understand customer behaviour and solve unseen pain points

  • How to successfully deploy AI, ML and advanced analytics: avoid over-complexity and inefficiency by ensuring your data management process and infrastructure are in order to enable quick adoption of new technologies
  • Educate to elevate. Ensure your data and digital literacy is of the highest caliber with a mindful approach to change management
  • Data governance: Discuss different buy or own models to find which approach will be the best fit for your purpose

Sital Kotecha Commercial Excellence Director, Growth Markets Sobi

Neelesh Shanbhag CIO & VP, Business Technology, Asia Pacific Janssen

Megan Hughes Global Head, Omnichannel Analytics Grunenthal

00:00am – 00:00am (CET)

Case study:How GSK apply marketing mixed modelling to understand channel and country performance against customer profiles fit for the digital-world

  • Bring together engagement, conversion, brand infinity, and financial metrics to refine your digital performance modelling
  • How to understand business impact for market growth

Denise Dewar Digital Hub Director GSK

00:00am – 00:00am (CET)

Sponsored Thought Leadership Opportunity

  • For more information, reach out to Henry Payne, Director of Business Development

00:00am – 00:00am (CET)

Case study:AI coming to the rescue: new technologies that enhance your business and customer intelligence capabilities

  • Create your data-organization, link multiple data sources - whether structured or unstructured - and build your predictive model to create customer behaviour profiles that can characterize new engagement opportunities
  • Scanning, characterizing available technologies and applying agile, design thinking processes to create a robust, end-to-end pilot to scale

Daniel Vertessy Business Development & Customer Intelligence Manager, DACH Region Aspen

00:00am – 00:00am (CET)

Live Q&A: Data centricity: for more intelligent decision-making and efficient commercial operations

  • Quiz our expert speakers on their case studies and their views on the future

Denise Dewar Digital Hub Director GSK

Daniel Vertessy Business Development & Customer Intelligence Manager, DACH Region Aspen

Assemble your new data and digital salesforce

00:00am – 00:00am (CET)

Fireside:Hybrid engagement is here to stay – but how do you decide to what degree?

  • Develop a holistic view of your customer-facing teams for more systematic and tailored operations management
  • Less time spent travelling is your field team’s opportunity to chase more value-add opportunities
  • How to vanquish the hybrid model rep fear factor and develop your change management initiative

00:00am – 00:00am (CET)

Panel:Increase your SFE with performance management approaches and capability building fit for hybrid engagement

  • Bridge the gap between your virtual and F2F capabilities through a thorough understanding of each environment’s strengths (and weaknesses)
  • More than call rates: How to change your incentives structure to reflect the shift to hybrid, customer relationship building and interactions
  • Soft selling in the virtual environment is the key to relationship building and devising common value for future success

Alexey Cherchago Head of Sales Excellence, Europe Sandoz

Dirk Abeel Global Medical Sales Director Reckitt Benckser

Chris Mann Head of Commercial Excellence, UK & Ireland Amgen

00:00am – 00:00am (CET)

Case study:Unify your messaging for increased customer-value

  • Devise a plan for your account management with prioritization without ignoring customers who can still climb the adoption ladder
  • How to keep your field focused on in-call excellence in combination with the omnichannel strategy
  • Correct use of your CRM to unlock the value of your KAM strategy

00:00am – 00:00am (CET)

Sponsored Thought Leadership Opportunity

  • For more information, reach out to Henry Payne, Director of Business Development

00:00am – 00:00am (CET)

Case study:The Virtual Rep

  • New Job Listing: Excellent sales skills, call ethic and experience in customer relationship building required. Technology fluent, not necessary but highly valuable. Must be flexible and willing to learn
  • Define how the virtual rep fits into your sales planning and funneling leads
  • When high customer experience demands combine with virtual selling expectations and goals – how to bridge the gap

00:00am – 00:00am (CET)

Live Q&A: Assemble your new data and digital salesforce

  • Quiz our expert speakers on their case studies and their views on the future

Digital innovation as your competitive advantage

00:00am – 00:00am (CET)

Fireside:Transformative digital technologies start with an alignment of business objectives and outcomes

  • How Almirall used the expertise of its Digital Garden entrepreneurs to create their own intrapreneurs to boost the efficiency and effectiveness of digital operations
  • Solving for the commercial imperative. Partner with start-ups as they still develop their business models, whilst also collaborating with established companies who can deliver on strategy right away

Francesca Wuttke Chief Digital Officer Almirall

00:00am – 00:00am (CET)

Panel:From ideation to commercial success. Crack the digital innovation model

  • Explore what a solution could be by rapidly building and testing iterations. What capabilities are needed for your lighthouse projects
  • Different commercial models for your digital projects to ensure innovation doesn’t perish. How to choose between spinning the project out, creating a new BU, adding as a companion and everything in between for your project
  • Translators and Navigators. Finding internal champions and working with partners that can deliver on your vision

Chris Easton Senior Director, Global Commercial Lead, Personalized Health & Innovation, Rare Hematology Takeda

Ignacio Quiles Lara VP, Commercial & Business Unit Head, Iberia GSK

00:00am – 00:00am (CET)

Case study:UCB: Develop a mature innovation strategy via an internal audit of capabilities and external search for partners that fill the gaps

  • Empower your teams to capatilise on urgent opportunities and prepare for the future through, digital mindsets and culture, data, strategy and capabilities
  • Beyond the companion app. With slow uptake of digital companions, how to look for opportunities outside your brands and to find your competitive advantage
  • Case Study: How UCB are reshaping care pathways and increasing diagnosis through external tech partnerships

Erik Janssen VP, Digital Transformation UCB

00:00am – 00:00am (CET)

Sponsored Thought Leadership Opportunity

  • For more information, reach out to Henry Payne, Director of Business Development

00:00am – 00:00am (CET)

Case study:Shape your digital innovation model and capitalize on new commercial opportunities

  • An assessment of fit-for-purpose technology that enables quick adoption without losing flexibility
  • How a collaborative business model enables you to fast-track development and improve digital innovation

00:00am – 00:00am (CET)

Live Q&A: Digital innovation as your competitive advantage

  • Quiz our expert speakers on their case studies and their views on the future

Erik Janssen VP, Digital Transformation UCB

Create value+ and personalised content for HCP engagement

00:00am – 00:00am (CET)

Fireside:From Push-to-Pull: How to change your content creation approach to meet new customer needs

  • Relying on push marketing is to ignore what customers want. Rebalance your promotional and non-promotional content and usher in a new generation of pharma content
  • Abandon the one-size-fits-all ship. How to identify gaps in creating personalized content and align your capabilities to customer needs

Oscar Perez Chief Marketing, Market Access & Business Development Officer Ferrer

00:00am – 00:00am (CET)

Panel:Execute a fit-for-multiple-environments content strategy with agile, iterative and customer tailored processes

  • Orientate your content to value by understanding customer needs and then connect the dots for a holistic customer experience
  • How to create content which is unbranded or beyond disease that can create behavior change
  • Chasing consumer brands. Is the customer experience pursuit of Amazon and Apple harming pharma’s ability to deliver on customer-centricity
  • Hear what types of content are having the greatest effect on customers right now

Vanitha S V Global Lead, Modular Content, Multichannel Excellence & Operations Novo Nordisk

00:00am – 00:00am (CET)

Case study:Sanofi: Interactive and personalised video content that mimics the F2F rep experience

  • Receive, recognize and resonate: Understanding HCP needs for value-driven content
  • Mimic the rep-experience and deliver closed-loop messaging through interactive video experience that personalizes the content based on the customer profile

Esra Caliskan Digital Initiatives Sanofi

00:00am – 00:00am (CET)

Sponsored Thought Leadership Opportunity

  • For more information, reach out to Henry Payne, Director of Business Development

00:00am – 00:00am (CET)

Case study:Scale personalisation by defining an MLR process fit for the digital world

  • Digital is an ever-evolving space. Learn how to work with compliance to ensure your frameworks for MLR evolve in parallel
  • Scale personalisation by stopping the bottleneck in promotional review processes to enable modular content and optimize content re-use
  • Conservative and compliant content can still be innovative. Create a digital review committee to devise a more efficient, collaborative MLR operation

00:00am – 00:00am (CET)

Live Q&A: Create value+ and personalised content for HCP engagement

  • Quiz our expert speakers on their case studies and their views on the future

Esra Caliskan Digital Initiatives Sanofi

Establish omnichannel frameworks. Deliver a connected customer experience

00:00am – 00:00am (CET)

Fireside:Make the move to omnichannel for a rounded customer experience and connected journey

  • Develop your roadmap to enable your omnichannel engagement strategy
  • How to ensure your messaging, content and channels are in-sync and tailored for a customer-centric strategy

00:00am – 00:00am (CET)

Panel:Capitalize on your customer engagement strategy through omnichannel

  • Set up frameworks and processes that allow you to roll out your omnichannel strategy for new products and markets
  • Be clear on each person’s role within the strategy – from marketing to the rep orchestrator
  • Use data and insights to understand customer preferences to create experiences that address needs and drive engagement
  • How to ensure your brand strategies are aligned with the customers omnichannel journey

Denis Vallese Global Omnichannel Strategy Lead AstraZeneca

Hans Gilhuys Senior Director, Commercial Digital Gilead

Adela Schulz iEU DBT Strategy & Capabilities Lead, EU Strategy and Operations UCB

00:00am – 00:00am (CET)

Case study:Omni-measurement for omnichannel effectiveness – how to improve your customer’s experiences and stay aligned to business goals

  • A successful strategy will be defined by your ability to measure and optimizing channel selection. Personalize the channel selection for key segments.
  • Understand how to use AI/ML in your strategy and where advanced analytics can help you prioritise channels, optimise content and educate your Next Best Action for engagement

00:00am – 00:00am (CET)

Sponsored Thought Leadership Opportunity

  • For more information, reach out to Henry Payne, Director of Business Development

00:00am – 00:00am (CET)

Case study:The Rep Orchestrator

  • Play an active role in content development and personalise modular content for your customers
  • Don’t be afraid to start small with only a 2-3 channels. Being realistic about channel planning and prioritization
  • Teach reps to understand data trends and insights, without requiring them to become data-scientists

00:00am – 00:00am (CET)

Live Q&A: Establish omnichannel frameworks. Deliver a connected customer experience

  • Quiz our expert speakers on their case studies and their views on the future

The new engagement model for Medical Affairs

00:00am – 00:00am (CET)

Fireside:Achieve best-in-class Medical Affairs engagement for the future

  • Deliver a personalised stakeholder experience through a multichannel strategy that balances physical and virtual interactions
  • Reimagine performance metrics across all HCP interactions to foster a physician-centric cultural transformation across your entire company and continuously recalibrate engagement models to meet evolving customer needs
  • Witness the future of Medical Affairs-led product launches that deliver a more valued HCP experience and market changing impact

Maha Radhakrishnan Chief Medical Officer Biogen

00:00am – 00:00am (CET)

Panel:A personalised, digitally enabled, multi-channel engagement strategy: Medical Affairs’ new normal

  • Cure your physician’s virtual hangover by creating a seamless multi-channel journey that aligns to personal preference and adds value to their daily patient interactions
  • Stand out in the crowded-digital environment by using social listening to deliver actionable insights from every interaction to inform your engagement approach
  • Optimise your physician experience through data-driven insights that personalise your dynamic content and channel strategy

Kumaran Krishnan Medical Excellence & Digital Transformation Expert

00:00am – 00:00am (CET)

Case study:“Hey Google, talk to Bayer Pharmaceutical.” How Bayer has enhanced HCPs access to medical information through Virtual Voice Assistant (AMI)

  • Learn how Bayer’s Medical Affairs team drove a cross-functional approach to pioneer innovative technology adoption inspired by analysis of physician need
  • Discover how to enhance your physician’s experience by providing faster access to relevant information through voice technology
  • See the blueprint for introducing voice technology to your company

Wagdy Youssef Senior Director US Medical Communication, Medical Information, Publication & Digital Transformation Bayer

00:00am – 00:00am (CET)

Case study:Expand your reach by embracing the new-generation of scientific – how to identify and work with Digital Opinion Leaders #Trending #DOLs #MedicalAffairs

  • Learn how to identify the right DOLs to champion your content and enhance your reputation across new physician demographics
  • Capture a wide range of insights from your DOLs engagement activity that can refine strategy across all channels, not just social

00:00am – 00:00am (CET)

Sponsored Thought Leadership Opportunity

  • For more information, reach out to Maddie Sheard, Director of Business Development

00:00am – 00:00am (CET)

Live Q&A: The new engagement model for Medical Affairs

  • Quiz our expert speakers on their case studies and their views on the future

Wagdy Youssef Senior Director US Medical Communication, Medical Information, Publication & Digital Transformation Bayer

Reimagine your Medical Affairs capabilities

00:00am – 00:00am (CET)

Fireside:Pharma’s third pillar: Medical Affairs. Deliver value across the organisation from your seat in the boardroom

  • Embody the voice of patients and physicians within your organisation to ensure stakeholder centricy is ever-present
  • See how a separate and independent Medical Affairs function can prosper to deliver added value to the business

Harmony Garges Chief Medical Officer ViiV Healthcare

00:00am – 00:00am (CET)

Panel:Modernise Medical Affairs: The new skills, roles and capabilities needed for engagement success in the new healthcare environment

  • Create a team capable of delivering a mature multi-channel strategy by upskilling the digital competencies and soft skills of your Medical Affairs workforce
  • Achieve new levels of external value by forging new roles and responsibilities the reflect the changing image of physician need
  • Create global-to-local structures that provide support and flexibility to empower and inspire local teams to personalise their HCP engagement strategies

00:00am – 00:00am (CET)

Case study:How AstraZeneca International reimagined their Medical roles and responsibilities around changing HCP and patient needs

  • Recruit data-savvy Medical Affairs operatives to optimise your data collection and insight generation processes
  • Understand why AstraZeneca created new roles for Medical Educators and Clinical Science Liaisons to shape the primary care ecosystem and ensure the best patient experience / outcomes

Alex Bedenkov VP, Medical International & Global Health Innovation Hubs Network Head AstraZeneca

00:00am – 00:00am (CET)

Case study:And in the beginning… How to create a decentralised Medical Affairs organisation from scratch

  • Learn how a decentralised approach to building a Medical Affairs organisation during the pandemic has enabled faster expansion of influence across Europe
  • Integrate evidence generation into the fabric of your Medical Affairs function across clinical and commercial to deliver an agile content creation strategy

00:00am – 00:00am (CET)

Sponsored Thought Leadership Opportunity

  • For more information, reach out to Maddie Sheard, Director of Business Development

00:00am – 00:00am (CET)

Live Q&A: Reimagine your Medical Affairs capabilities

  • Quiz our expert speakers on their case studies and their views on the future

Alex Bedenkov VP, Medical International & Global Health Innovation Hubs Network Head AstraZeneca

The new face of Field Medical

00:00am – 00:00am (CET)

Fireside:MSLs Assemble! Pharma’s new leaders for field engagement strategy in post-pandemic healthcare

  • See how your MSL team can be driving force of external engagements going forwards by demonstrating improved value by building physician trust through with higher quality content and interactions
  • Expand the influence of your field medical teams to lead physician-centric cross-functional strategy with KAMs and commercial reps

00:00am – 00:00am (CET)

Panel:Equip your field medical teams to flourish through the hybrid transformation

  • Find the balance of physical and virtual interactions to prevent physician fatigue and provide personalised experiences that truly deliver an MSL-led omnichannel experience
  • The digital MSL: Embed digital as a core competency of your field medical team to deliver the now essential physician-centric strategy
  • Enable your field medical team to communicate your scientific storytelling fluidly across different channels to personalise and optimise their engagements

Maja Beilmann-Schramm Director, Global Field Medical Excellence & HCP Exchange Merck Group

00:00am – 00:00am (CET)

Case study:Omnichannel orchestrator. The new requirement for your MSLs.

  • Empower your MSLs with data-derived insights that inform a personalised engagement strategy
  • Situate your MSL teams as the bridge between internal and external stakeholder management to deliver insights across the business

00:00am – 00:00am (CET)

Case study:Metrics managed! How multi-channel can finally solve your performance metrics headache

  • Learn how your multi-channel engagement strategy allows you to qualitatively assess virtual engagements and refine future strategy
  • Benchmark MSL engagements across therapy and regions to spot and scale excellence

Heather Moses Country Medical Director, Oncology, UK Novartis

00:00am – 00:00am (CET)

Sponsored Thought Leadership Opportunity

  • For more information, reach out to Maddie Sheard, Director of Business Development

00:00am – 00:00am (CET)

Live Q&A: The new face of Field Medical

  • Quiz our expert speakers on their case studies and their views on the future

Heather Moses Country Medical Director, Oncology, UK Novartis

Patient quality of life: Your new access priority

00:00am – 00:00am (CET)

Fireside Chat: Balance the needs of access stakeholders to ensure a more collaborative future and advance patient care

  • Discover how Sanofi assess the value of collaboration and incorporate varied stakeholder perspectives from diagnosis to treatment and long-term patient journeys
  • Understand your role in aligning all stakeholders to enable patients to live life without limits, predicting the future of decision-making to drive sustainable access
  • How to anticipate new global healthcare marketplace trends in an era of unrecognised change to address unmet needs as a community

Vanessa Wolfeler Global Franchise Head, Rare Blood Disorders Sanofi Genzyme

00:00am – 00:00am (CET)

Panel:A roadmap for value-based care post-pandemic: It’s now or never to improve patient outcomes

  • One for all or all for one? Ensure a sustainable market for mainstream drugs that can withstand the shift to outcome-based therapies
  • Assess the wider societal and patient implications of the shift towards personalised precision medicine
  • Align contradictory stakeholder objectives to drive the adoption of value-based healthcare out of the pandemic

Martin Price VP, Health Economics, Market Access & Reimbursement, Janssen

Ulf Staginnus SVP, Head Global Market Access & Pricing Ipsen

Sylvie Greneche Head of Global Market Access, General Medicines Sanofi

00:00am – 00:00am (CET)

Case study:Drive access to medical innovations with early-stage patient and payer engagement - Etranacogene dezaparvovec C> case study

  • Discover how CSL Behring overcame barriers to patient engagement and facilitated continues access to treatment through ‘easy telemedicine’ a project to redesign the patient journey using existing communication platforms
  • Understand how early stage engagement with patients and payers is guiding the HTA approval and reimbursement process for Etranacogene dezaparvovec, the first-ever gene therapy approved for hemophilia B
  • Learn how CSL Behring is build patient confidence in access innovations through collaboration and education

Lara Pippo Head, Market Access & Government Affairs CSL Behring

00:00am – 00:00am (CET)

Case study:Value, access and reimbursement of gene therapies for rare genetic disorders - Zolgensma case study

  • Understand why gene therapies for rare genetic disorders require healthcare systems to re-envision how they value one-time transformative therapies
  • Discover how to achieve cross-collaboration at a European level and why it’s the key to securing patient access to innovative gene therapies
  • Zolgensma case study: Discover how Novartis Gene Therapies developed bespoke solutions to support rapid access within European healthcare systems

Mike Fraser General Manager, Europe, Middle East & Africa Novartis Gene Therapies

00:00am – 00:00am (CET)

Live Q&A: Patient quality of life: Your new access priority

  • Quiz our expert speakers on their case studies and their views on the future

Lara Pippo Head, Market Access & Government Affairs CSL Behring

Mike Fraser General Manager, Europe, Middle East & Africa Novartis Gene Therapies

Scale new market access models: Pricing, partnership and digital innovation to ensure health equity

00:00am – 00:00am (CET)

Fireside chat: The imperative of equal access to treatment: How Bristol Myers Squibb is working to meet diverse needs across the European access market

  • Understand how differences in market authorization across Europe results in vast disparities for patient access
  • Discover All.Can, an international multi-stakeholder organisation empowering collaboration for improved outcomes in cancer care
  • Learn how BMS is working to make Opdivo available in the West Balkans region

Ester Banque SVP and Head, Intercontinental Bristol Myers Squibb

00:00am – 00:00am (CET)

Panel:The digital disruption of market access

  • Understand how integrated digital healthcare ecosystems are driving the future of payer relationships and collaboration
  • Discover how the digital transformation is reshaping access, from value propositions to healthcare delivery
  • Build the capabilities needed to leverage digital innovation, from data management and AI to evidence generation, digital adaptative dossiers and stakeholder interactions

Raquel Riol Head, Market Access AMESA region Sanofi

Adam Kundewicz Head, Global Strategic Market Access Initiatives Boehringer Ingelheim

Clare Hague Senior Director, Therapy Area Market Access Leader, Hematology Janssen

00:00am – 00:00am (CET)

Presentation: Collaboration as the key to accelerating the new market access model

Jackie Williams General Manager, UK Astellas

00:00am – 00:00am (CET)

Case study:Entresto. How a patient-centric global mindset drove regulatory innovation and accelerated approval and reimbursement

  • Discover how Novartis Albania utilised FDA approvals to become the second country in Europe to register Entresto, fast-tracking beyond the EMA
  • Understand how to use patient engagement and public health campaigns to accelerate reimbursement
  • Learn how the multilateral success of Entresto has shaped the culture of access in Novartis Albania, driving the adoption of greater multifunctional collaboration and shaping patient engagement strategies

Melissa Troshani Head, Patient Access Public Affairs Novartis

00:00am – 00:00am (CET)

Live Q&A: Scale new market access models: Pricing, partnership and digital innovation to ensure health equity

  • Quiz our expert speakers on their case studies and their views on the future

Jackie Williams General Manager, UK Astellas

Melissa Troshani Head, Patient Access Public Affairs Novartis

Patient centricity in practice across the value chain

00:00am – 00:00am (CET)

Beyond centricity: move beyond cultural acceptance to scale action and champion patient voices from R&D to commercial

  • From building and maintaining long-term stakeholder relationships to synced and centered insights across the global – explore the scope of the new patient-centric requirements
  • The impact of rising patient-centric adoption on international healthcare trends; from the emergence of patient advisory efforts in non-traditional markets, to the increasing impact of patient experience data across sponsor, regulatory and market access stakeholder decision-making
  • Empower your teams with the tools they need to deliver the impacts of patient centricity, from faster innovation to wider patient access, and a reduction in cost and time to market

Vicky DiBiaso Global Head, Patient Informed Development & Health Value Translation Sanofi

00:00am – 00:00am (CET)

Panel:The new benchmarks of great patient engagement

  • How to measure “success” across all touchpoints and platforms across your organisation, from face-to-face to new digital and automated tools, and legitimize your benchmarking results
  • Determine novel outcomes based on real patient need with a flexible disease appropriate approach to platforms, technologies and engagement plan
  • Shift from quantitative to qualitative: Identify, adopt and implement quality-of-life and tangible benefit KPIs in your patient engagement strategy

Shannon Altmari Global Head, Advocacy to Outcomes GSK

Teresa Ferreiro Patient advocate

00:00am – 00:00am (CET)

Case study:Systematize patient engagement with the PARADIGM digital tool

  • Discover how Janssen used PARADIGM, a digital patient engagement insight and analysis tool to systemize patient engagement throughout the company across disease strategies
  • How Janssen built a cross-organisation platform and glossary for patient engagement using PARADIGM to structure the collection, organization and application of patient insights across EU sites.
  • Learn how to assess the success and usefulness of pre-existing core activities, restructure existing strategies and reform community engagement based on insights formed with the PARADIGM methodology.

Daniel de Schryver Patient Engagement & Advocacy Lead, EMEA Janssen

00:00am – 00:00am (CET)

Case study:Operationalizing the Embracing Carers™ initiative to unlock new pathways to patient-drive innovation

  • How the pandemic has impacted unpaid carers: New results of the Carer Well-Being Index which surveyed over 9,000 respondents in Europe, Asia, and the Americas to understand economic, physical and mental well-being impacts
  • Understand how caregiver engagement can help provide you with a multitude of valuable new patient insights and unlock pathways to innovative clinical outcomes
  • Explore the practical steps used to operationalize caregiver insights within trial design in the phase III programme for Investigational Evobrutinib in Relapsing Multiple Sclerosis.

Vanessa Pott Director, Global Patient Insights & Advocacy Merck Group

00:00am – 00:00am (CET)

Live Q&A: Patient centricity in practice across the value chain

  • Quiz our expert speakers on their case studies and their views on the future

Vanessa Pott Director, Global Patient Insights & Advocacy Merck Group

Daniel de Schryver Patient Engagement & Advocacy Lead, EMEA Janssen

Reimagine digital patient engagement to reach diverse patient populations and gain real-world journey understanding

00:00am – 00:00am (CET)

Fireside chat: Patient engagement and pharma’s digital responsibility

  • Define pharma’s societal responsibility to set and achieve ethical standards for digital leadership
  • Understand the role of digital innovation and leadership to safeguard against data biases and ensure greater diversity and equity in patient engagement and outcomes. Understand the role of digital innovation to drive pharma towards a more diverse and equitable future
  • Deliver meaningful value to the patients, caregivers and society through economically, socially and environmentally sustainable progress towards patient-centric digital engagement

00:00am – 00:00am (CET)

Panel:Employ innovations in digital engagement to empower a new generation of patient advocates

  • Explore the changing relationship between patients and HCPs and how you can fill the widening education and support gap
  • Employ innovative tools and platforms to build a multichannel engagement and educational strategy that will facilitate patient engagement across a more diverse patient audience
  • Engage a younger generation of advocates to reach new patient populations and gain more varied insights: The world of social media and health influencers
  • Give back with digital: Discover how we can repurpose our digital engagement expertise to support advocates and organizations.

Christina Kotsi Patient Engagement & Insights Project Manager Novartis

Geoff Rollason Director, Patient Experience & Service, Oncology, UK Pfizer

Mark Sterckel Sr. Patient Engagement Director Ferring Pharmaceuticals

00:00am – 00:00am (CET)

Case study:“Janssen with me” – a one-stop-patient community platform to improve patient education and connectivity

  • How Janssen built and ensured the real-world value of their new patient content platform, “Janssen with me”, to provide education, community, and support to patients, caregivers and patient organizations across 6 therapy areas and multiple geographies
  • Deliver greater ROI through platform streamlining, from reduced platform cost to measurable engagement statistics
  • How ensuring high-quality, reliable, and digestible content can build greater patient trust in your organization and drive industry reputational recovery
  • Empower patient to patient connections to build a connected and empowered community: How Janssen with me is overcoming regulatory hurdles to build support networks based on shared patient needs

Kim Searle EMEA Patient Web Platform Manager Janssen

00:00am – 00:00am (CET)

Case study:Ensure patient connected health objectives across the entire patient journey to drive personalised care pathways

  • Discover how Novartis is leveraging digital assessments of mobility characteristics in Osteoarthritis and across various indications
  • Understand Novartis are employing novel AI and ML innovations to build patient and physician understanding of individualized mobility characteristics and drive personalized support and educational interventions
  • Employ a fully managed end-to-end engagement programme across the patient journey to drive long-term and short-term patient health objectives and empower patient ownership of individual health

Panos Papakonstantinou Global Digital Health Solutions Director, Immunology Hepatology & Dermatology Novartis

00:00am – 00:00am (CET)

Live Q&A: Reimagine digital patient engagement to reach diverse patient populations and gain real-world journey understanding

  • Quiz our expert speakers on their case studies and their views on the future

Panos Papakonstantinou Global Digital Health Solutions Director, Immunology Hepatology & Dermatology Novartis

Kim Searle EMEA Patient Web Platform Manager Janssen